Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
EMA Recommends Dozens Of Suspensions Over Flawed Synchron Studies
Generic Marketing Authorizations To Be Suspended Following Similar Criticism From US FDA
May 27 2022
•
By
David Wallace
Marketing authorizations linked to Synchron data will be suspended • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Europe
More from Geography